Ethylmethylglyoxal bis(guanylhydrazone) (EM GBG) sulfate, an analog of the well-known anti leukemic drug methylglyoxal bis(guanylhydrazone), was synthesized. It was shown to be an extremely powerful competitive inhibitor of eukaryotic S-adenosylmethionine decarboxylase, with an apparent K{ value 12 n M . Thus, it appears to be the most powerful known inhibitor of the enzyme, being almost an order of magnitude more powerful than the corresponding ethylglyoxal derivative. It neither inhibited the proliferation of mouse L1210 leukemia cells in vitro, nor did it potentiate the growth inhibition produced by a-difluoromethyl ornithine. In this respect, its properties are closely related to those of dimethylglyoxal, ethylglyoxal and propylglyoxal bis(guanylhydrazones), while in striking contrast to those of the antiproliferative glyoxal and methylglyoxal analogs. EMGBG also inhibited intestinal diamine oxidase activity (K, 0.7 |xm). EM GBG sulfate was crystallized from water, giving orthorhombic crystals (space group Pbcn). Their crystal and molecular structure was determined by X-ray diffraction methods. The carbonnitrogen double bonds between the ethylmethylglyoxal part and the aminoguanidine moieties were found to have the same configuration as they are known to have in the salts of glyoxal, methylglyoxal and propylglyoxal bis(guanylhydrazones). The glyoxal bis(guanylhydrazone) chain of the EMGBG cation deviated strongly from planarity, thus differing dramatically from the corresponding chains of the glyoxal, methylglyoxal and propylglyoxal analogs.
Introduction
In 1958, Freedlander and French [1] reported the antileukemic activity of the bis(guanylhydrazones) GBG [2] and MGBG [2] (Fig. 1) . Since that time, a great number of derivatives were screened for anti tumor activity (for references, see [3] and [4] ), but it was found that minor modifications, such as dialkylation of the glyoxal moiety, resulted in the loss of antitumor activity [3, 4] , In 1972, Williams-Ashman and Schenone [5] found that MGBG powerfully inhibits S-adenosylmethionine decarboxylase and hence the synthesis of spermidine and spermine. This discovery drastically stimulated the interest in this class of compounds, but it soon became evident that no relationship existed between the inhibition of this enzyme and the antileukemic activity. Thus, al though EGBG [2] and DMGBG [2] were known to be devoid of antitumor activity [3] , they were found to be much more effective inhibitors of S-adenosyl methionine decarboxylase than were GBG and MGBG [6, 7] , The lack of antitumor activity is possi bly due to the fact that EGBG and DMGBG are only poorly taken up by mammalian cells [7, 8] via the putative polyamine carrier [9] inducible by poly amine depletion [10] .
On the basis of the data so far accumulated, it appears that compounds such as EGBG and DMGBG are much more specific inhibitors of poly amine biosynthesis than is the parent compound GBG and do not display the profound antimito chondrial activity typical of MGBG [8, 11 -13] . Thus, the compounds are valuable tools in poly amine research. When S-adenosylmethionine decar boxylase inhibition is considered, the K \ values of monoalkylglyoxal bis(guanylhydrazones) decrease from GBG (6 jim) through MGBG (0.2 |^m) to EGBG (0.06 (im) [14] . After the monoethyl stage, however, the value begins to increase again, the K \ value of PGBG [2] being 0.2 jam [15] , and it is obvi ous that among all members of the series of mono alkyl derivatives, EGBG is the most powerful in hibitor of S-adenosylmethionine decarboxylase. On the other hand, the addition of a second methyl sub stituent to the glyoxal moiety of MGBG also leads to a decrease of the Kx value. Thus, DMGBG is a clear ly stronger inhibitor of the enzyme than is MGBG [7] . On this basis, we concluded that the addition of a methyl group to the glyoxal part of EGBG might considerably increase the inhibitory power of the compound. Therefore, we have now synthesized the sulfate salt of that compound, EMGBG [2] , and have studied its biochemical properties and determined the crystal and molecular structure of the compound. The results of these studies are reported here.
Materials and Methods

Synthesis of E M G B G sulfate
Aminoguanidine bicarbonate (28.69 g, 0.211 mol; Aldrich, Steinheim, West-Germany) was dissolved in 0.42 M aqueous sulphuric acid (400 ml) at room temperature. This solution was then added with stirring to a solution containing 2,3-pentanedione (10.44 g, 0.104 mol; Aldrich) in absolute ethanol (200 ml). With continuous stirring, the mixture was warmed to about 90 °C and was then allowed to cool. Thus, the yellow color of the mixture disappeared and a small white precipitate appeared. Stirring of the mixture gave a further precipitate. As it was not known, whether the precipitate contained unreacted aminoguanidine sulfate, the mixture was gently re fluxed for 30 minutes, allowed to cool to room tem perature and then cooled in an ice bath. The white precipitate was collected by filtration, washed with a small amount of water and air-dried (yield 27.5 g. 81%). (More product could be obtained from the combined filtrate and washings after standing at room temperature for several days and cooling in an ice bath.) For recrystallization, the crude product was dissolved in water (1500 ml) at 90 °C. 1300 ml of the solution obtained was cooled in an ice/water bath, the precipitate formed was filtered off, washed with a small amount of water and air-dried (yield 10 g, 42% recovery). Analysis: found C, 25.51%, and H, 5.93%; calculated for C7H 16N8-H 2S0 4 -H20: C, 25.60%, and H, 6.14%. This lot was used for the biochemical studies. (More product (7 g) was ob tained from the filtrate as it was allowed to concen trate at room temperature.) The remaining 200 ml lot of the recrystallization solution was used for crys tal growing for the X-ray study. Thus, it was allowed to concentrate at 65 °C during 4 days to the volume of about 120 ml, the crystals obtained were filtered off, washed with a small amount of cold water, dried in a desiccator for 2 days and transferred to an air tight bottle. The product had a white to very faintly greenish appearance.
Biochemical measurements
S-adenosylmethionine decarboxylase inhibition was studied according to previously published proce dures [7, 16] . Intestinal diamine oxidase inhibition was studied according to the method of Tryding and Willert [17] .
Mouse L1210 leukemia cells were grown in Gibco's medium RPMI 1640 supplemented with 5% (v/v) of pooled human serum (Finnish Red Cross Trans fusion Service), 2 mM glutamine, and 50 mg of the sodium salt of penicillin G and 50 mg of strepto mycin per litre. 
Crystallographic measurements
The colourless crystal selected for intensity data collection had the dimensions of 0.50x0.30x0.30 mm. The cell parameters were determined by least-squares treatment of the adjusted angular settings of 20 reflections measured on a Nicolet P3F diffracto meter. The intensity measurements were carried out at room temperature (21 ± 2 °C) with graphite monochromatized MoKa radiation and the co-scan technique. The scan rate varied from 2.5 to 29.3° min-1, depending on the number of counts measured in a fast preliminary scan. Up to a max imum value of 2 0 = 50°, 2868 reflections were meas ured, resulting to a set of 2504 unique reflections. Of these 1472 were considered as observed (I > 2a(I)). Standard reflections (113, 172, 436) monitored periodically exhibited no significant variation. The intensities were corrected for Lorenz and polariza tion effects but corrections for absorption and extinc tion were considered unnecessary.
Systematic absences (Okl, k = 2n + 1; hOl, 1 = 2n + 1; hkO, h + k = 2n + 1; hkl, no restric tions) established the space group as orthorhombic Pbcn (No. 60). The density was measured by flota tion in a toluene-CCl4 mixture.
The structure was solved by direct methods [18] and successive Fourier syntheses [19] . The hydrogen atoms were not determined. Full-matrix leastsquares refinement with all atoms as anisotropic led to R = z | |f o| -|FC| |/|f o| = 0.070 and R w = (Z w (|fo| -| f c|)2/Z w |fo|2)1/2 = 0.072, where w = l/o(F0)2. After the last cycle, the A/oav = 0.0002 and A/amax = 0.001. In the final difference map the Aq peaks were between 0.58 and -0.50 eÄ-3. Scattering factors were from Cromer and Mann [20] and the anomalous dispersion corrections were applied [21] . All calculations were carried out on a UNIVAC 1100/61 E l computer.
Results and Discussion
As shown in Fig. 2 , EMGBG acted as a competi tive inhibitor of S-adenosylmethionine decarboxy lase with an apparent K \ value as low as 12 nM. Thus, its inhibitory power is almost an order of magnitude greater than that of EGBG, and it seems to consti tute the most powerful known inhibitor of the enzyme. The compound also inhibited intestinal diamine oxidase activity, yet the value (0.7 (jm) was much higher than that for adenosylmethionine decarboxylase.
At the concentrations tested (5 to 200 |xm), EMGBG did not inhibit the growth of cultivated L1210 mouse leukemia cells, nor did it potentiate the iS m M _ l Fig. 2 . Inhibition of S-adenosylmethionine decarboxylase by EM GBG.
growth inhibition produced by a-difluoromethyl ornithine (results not shown). These findings are in line with those given in the only previous report on EMGBG [22] , which states that EMGBG dihydro chloride dihydrate is inactive against KB cells in cul ture and against leukemia L1210 in vivo. In this respect, the compound clearly falls in the category constituted by DMGBG, EGBG and PGBG, and is distinctly different from the anti-proliferative analogs GBG and MGBG.
The X-ray study on EMGBG sulfate revealed that the carbon-nitrogen double bonds between the ethylmethylglyoxal part and the aminoguanidine moieties had the same configuration as they are known to have in the salts of GBG, MGBG and PGBG [23] [24] [25] . Thus, the biochemical differences between these compounds cannot be due to differences in the configurations of double bonds. An ORTEP drawing [26] and the numbering scheme of the EMGBG ca tion are shown in Fig. 3 and a perspective view in N(2) Fig. 3 . An ORTEP drawing and the numbering scheme of the EM GBG cation. The thermal ellipsoids are drawn at the 50% probability level. Fig. 4 . Bond lengths and angles are shown in Fig. 5 and the packing in Fig. 6 . The atomic coordinates and the equivalent values of the anisotropic tempera ture coefficients [27] are listed in Table I .
The bond lengths and angles of the EMGBG ca tion agree well with those of other glyoxal bis(gua- 
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116.6(6)' 119.7(7) , 112.9 (6) At this stage, it is difficult to predict, whether this deviation from pla narity is an intrinsic property of the EMGBG cation or whether it is a result of packing effects or of the hydrogen bond system in EMGBG sulfate crystals. The crystal structure consists of stacked pairs of EMGBG cations (Fig. 6) . The mean distance be tween the EMGBG cations is about 4.1 Ä. The crys tal system is held together by an extensive hydrogen bond network through the S 0 42-ions.
It would be very important to find out the reason for the striking deviation from planarity of the EMGBG cation in EMGBG sulfate, because such a deviation probably has profound effects on the de gree of delocalization of Ji-electrons in the ion. Such changes may in turn affect the biochemical proper-ties of the compound. Therefore, studies on the crys tal structures of other salts of EMGBG are war ranted, as they probably would reveal, whether the deviation from planarity is an intrinsic property of the EMGBG cation.
Supplementary material available
Temperature factor and structure factor tables of EMGBG sulfate are available from the authors (H. E. and I. M.) on request.
